Director, HTA, Evidence, Global Access

🕒 Abril 30

Candidatar-se

Encontrar Vagas Remotas Similares

Receber Emails de Vagas Remotas

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Enviar Currículo

Iovance Biotherapeutics, Inc.

SiteLinkedInTodas as Vagas

501 - 1000 funcionários

Fundada em 2014

🧬 Biotecnologia

💊 Farmacêutico

⚕️ Seguro de Saúde

Biotechnology • Pharmaceuticals • Healthcare Insurance

A Iovance Biotherapeutics, Inc. está revolucionando o tratamento do câncer ao aproveitar a capacidade do sistema imunológico humano de reconhecer e atacar células cancerígenas diversas em cada paciente. A empresa se concentra em imunoterapia baseada em células T, especificamente a terapia com Linfócitos T Infiltrantes de Tumor (TIL), que consiste em revigorar os TILs de um paciente para combater o câncer. A terapia TIL da Iovance está sendo investigada em ensaios clínicos para diversos tipos de câncer sólidos avançados. Além disso, a empresa está avançando em terapias TIL geneticamente modificadas e explorando aplicações potenciais da terapia PBL (linfócitos do sangue periférico) para cânceres hematológicos. Como líder em terapia celular, a Iovance possui um moderno Centro de Terapia Celular na Filadélfia para fabricar suas terapias utilizando GMP proprietária. A empresa está na vanguarda do desenvolvimento de tratamentos contra o câncer personalizados e específicos para cada paciente.

Descrição

• Support the development and maintenance of economic models and global value dossiers for HTA submissions, managing/directing market access and HEOR consultants. • Serve as project manager for global market access and HEOR activities, including tracking deliverables, coordinating document reviews, managing contracts, and ensuring alignment on timelines and cross-functional updates. • Support global HEOR research projects, including review of analyses and development of publications for HTA submissions and payer responses, in collaboration with the HEOR team. • Support development and execution of the evidence generation for payer needs in collaboration with medical affairs • Manage external engagements, in a compliant manner, with HTA agencies, payers, key opinion leaders, and other stakeholders • Communicate market access and HEOR strategy updates, insights, and recommendations to cross-functional partners and senior leadership. • Develop and adapt value and access materials for priority global markets. • Support planning and strategy for new indication launches, from the perspective of evidence and access • Monitor and proactively communicate market access changes, challenges, and opportunities in priority markets. • Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics. • Perform miscellaneous duties as assigned.

🎯 Requisitos

• 12+ years of relevant experience in the biopharmaceutical industry, with demonstrated expertise in health economics, outcomes research, market access, real world evidence and/or related functions. • Strong background in oncology, cell therapy, ATMPs, and/or rare diseases preferred. • Advanced degree preferred in a field related to HEOR (health economics, epidemiology, health services research or similar), or a medical field. • Experience and ability in developing strategic analyses and plans • Strong understanding of scientific, clinical, and real-world evidence, with the ability to communicate complex concepts clearly. • Excellent written and verbal communication skills, including significant experience presenting to executive-level audiences. • Highly organized with excellent project management skills • Deep understanding of international healthcare systems, including HTA processes, reimbursement frameworks, and health policy considerations across global markets. • Fluency in French or German would be an asset.